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Abstract: This review examines the causal investigation of preclinical development of childhood 
asthma using exposomic tools. We examine the current state of knowledge regarding early-life 
exposure to non-biogenic indoor air pollution and the developmental modulation of the immune 
system. We examine how metabolomics technologies could aid not only in the biomarker 
identification of a particular asthma phenotype, but also the mechanisms underlying the 
immunopathologic process. Within such a framework, we propose alternate components of exposomic 
investigation of asthma in which, the exposome represents a reiterative investigative process of 
targeted biomarker identification, validation through computational systems biology and physical 
sampling of environmental media. 
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1. Introduction 
Childhood asthma represents a heterogeneous set of conditions, in which, functional lung 
impairment, chronic inflammation, tissue remodeling, and response to therapy represent some 
hallmark events. In spite of phenotypic differences, a number of international guidelines point to 
airway inflammation control as the primary goal of therapy [1]. Another key event of asthma features 
altered development of the cellular and molecular components of the immune system prior to the 
appearance of the asthmatic phenotype [2]. 
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1.1. Burden of childhood asthma 
Allergic asthma, allergic rhinitis, and eczema represent the most common childhood chronic 
diseases in the industrialized world [3] . Worldwide, the mean prevalence of asthma is estimated to 
range between 5 and 25% for 6–7 age group [4], reflecting plateauing of prevalence within many 
industrialized countries. Worldwide, the mean prevalence of asthma is estimated to range between 5 
and 25% for the 6–7 age group [4], reflecting plateauing of prevalence within many industrialized 
countries [4,5]. Within United States (US), an estimated 13 ±                              1.7% of 
American Indian/Alaska Native        ±  0.2 % of White children suffer from asthma [6]. 
The economic toll of living with asthma is estimated at $37.2 billion for 2007 in the US alone[7]. 
An estimated 10.5 million school days were missed due to asthma between 2005–2009 [8]. 
Furthermore, the burden of asthma is disproportionately greater for low income and minority 
children[9]. 
 In spite of intensive on-going investigations on genetic [10], environmental [11], and 
lifestyle-related [9] risk factors, true causal processes remain unknown [12]. Known multiple classical 
allergens and adjuvants to date, including infiltrated ambient air pollutants, cockroach and cat dander, 
dust mites, mice allergens, and environmental tobacco smoke (ETS), do not adequately explain the 
burden of asthma in children [13,14]. Furthermore, current efforts have failed to stem the growing 
worldwide development of childhood asthma [15,16]. To date, early-life mechanisms underlying the 
childhood                   remain inadequately defined [15,16,17]. 
1.2. Aim and scope of this review 
Within this review, we examine the early-life exposure to emerging classes of environmental 
pollutants and their role in respiratory and immune system impairment. As pregnancy is often 
associated with longer daily hours spent within the indoor environment, the scope of this review is 
limited to environmental pollutants that pregnant women are exposed to within their residential indoor 
environment. Within this context, we also examine limited sunlight exposure and the resulting low 
level of vitamin D as a behavioral sequela of large daily hours spent within the indoor setting. 
Therefore, we focus here is the combined contributions of gestational vitamin D deficiency and indoor 
environmental pollutant exposures on pre-clinical immune functional impairments during the first few 
                ’      . Specifically, our goal is to assess the internal validity of exposomic approaches 
to clarify the mechanisms underlying developmental impairments of the immune system. Here we are 
concerned with the segment of the population which includes non-occupationally exposed pregnant 
women with a low risk of adverse birth outcomes. Thus, specific occupational exposures to physical or 
chemical respiratory risk factors lie beyond the scope of this analysis. Furthermore, classical risk 
factors, including specific genetic susceptibility contributors, viral, fungal and bacterial agents within 
the indoor environment, maternal nutritional qualities (such as low dietary intake of vitamin D), social- 
and/or economic- stresses, have already been examined in a number of other excellent 
reviews[11,18,19,20]. The risks of classical allergens and adjuvants will not be assessed within the 
present review.  
Based on the above considerations and within the context of asthma investigations, we assess the 
applicability and adaptability of the “ x                ”    a set of tools for a comprehensive 
exposure history characterization and as a health diagnostic tool for parents and infants. As previously 
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defined [21], the exposome is all exogenous factors (the environment) that can modify the endogenous 
host characteristics (genes and metabolic activities) that together influence health. The endogenous 
influences have been expanded to include the microbiome and the chimeric associations of pregnancy. 
For example, children with autism spectrum disorders (ASD) as well as maternal allergies, matenal 
psychological and socioeconomic difficulties, chemical, and biological (e.g. infection) stress during 
the pregnancy could contribute to increased risks of airway symptoms [22]. Interestingly, boys (6–8 
years of age) have more doctor-diagnosed asthma and ASD than girls [22].  
This review is composed of three sections. First, we lay the contextual framework of our 
discussion in terms of prenatal exposure to air pollution within a home indoor setting and its risks on 
asthma. Secondly, we examine the state of knowledge regarding exposure and outcome relationship. 
Thirdly, we propose novel components for exposomic investigation in light of the current gaps in 
knowledge regarding exposomic approaches as well as the future research direction for asthma 
biomarker validation. 
2. Methods 
A PubMed search was conducted using the search terms, asthma, immune, inflammation, 
oxidative stress, reactive oxygen species, lung, impairment, indoor, air pollution, prenatal, and 
childhood for peer-reviewed, primary research publications in the English language. 
3. Results and Discussion 
3.1.  Home: context of in utero exposures 
                       epidemiological evidence demonstrates that the indoor environment during 
early-life is critical to      occurrence of childhood asthma [11,23,24].                           
            report qualitative                                                             
             redecoration are at significantly greater risks of asthma and allergies [13,24,25].  x       
                                                energy conservation efforts for                  
            x                  promote indoor moisture buildup [26]  Home indoor dampness is 
estimated to be present in > 70% of the homes in upstate New York [27] and in > 50% of the homes in 
Europe [28]. Both adults and children spend an estimated >                     hours within an indoor 
setting [29]. Within a vulnerable segment of the population (e.g. elderly, pregnant women, and young 
children), the exposure to indoor toxicants are estimated to be higher because of sedentary 
behavior[29]. However, while qualitative reporting of dampness is an established risk factor of asthma, 
home indoor dampness overall poorly correlate with directly measured fungi, mycotoxins, and other 
biogenic markers [30]. Furthermore, a growing body of investigations has failed to demonstrate an 
association between directly measured fungal components and asthma [14,24]. Recent reviews point out 
the critical need for the identification of specific                                                     
                        allergy investigation [11,25].  
The exact mechanism through which a damp environment increases the risk of asthma inception 
     other lower airway allergic diseases remains unknown [23,24]. Another emerging line of evidence 
suggests home indoor dampness is correlated with modern chemicals [31]. Within a non-occupational 
setting, both new and                                                                PVC) has shown 
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to initiate or exacerbate asthma [32,33,34]. Sources such as PVC flooring or phthalate concentration in 
dust are significantly associated with a risk of asthma diagnosis [22,35]. Occupational exposure to 
painted surfaces have long been associated with eye irritation, skin itching, obstructive airway problems, 
and frequent urination in longitudinal follow-up studies [36,37,38,39,40,41]. 
However, exposure assessment of specific chemicals remains challenging. Data regarding 
temporal variability of the sources, emission, and human behaviors, and resulting human exposure 
remain scarce. The home indoor volatile organic compound (VOC)                                 
                                                         poor ventilation, humidity, and/or 
temperature va                       setting. 
3.1.1. Propylene glycol and glycol ethers, the forgotten endocrine disruptors 
A robust body of literature suggests that volatile organic compounds associated with cleaning 
tasks increases the risk of doctor-diagnosed asthma. Among the occupationally exposed adults, indoor 
sources such as cleaning spray, cleaning liquids, mechanical floor scrubbing, and window cleaning 
were significantly associated with risks of newly-onset asthma and other respiratory 
diseases[13,37,42,43,44,45]. Within a non-occupational setting, the children, whose homes had the 
highest 25% of propylene glycol and glycol ethers (PGEs) concentrations, had a 2.0-fold greater 
likelihood of having doctor-diagnosed asthma (95% CI, 0.9–4.4), a 4.2-fold greater likelihood of 
rhinitis (95% CI, 1.7–10.3), and a 2.5-fold greater likelihood of eczema (95% CI, 1.1–5.3) [46].  
PGEs are globally distributed as organic solvents and coalescents within cleaning agents, paints, 
pharmaceuticals, inks and consumer products (e.g., cosmetics, PVC, and glue) [40,47,48]. In various 
animal models, PGEs cause male sub-fertility and infertility, an increased time to pregnancy [49], 
oocyte depletion, spontaneous abortion, hematopoietic, immune (e.g., thymic) function suppression in 
adults, and transplacental fetotoxicities [48].  
3.1.2. Other volatile organic compounds of mistaken origin 
To date, a great deal of confusion exists regarding the true sources of common VOCs of indoor 
origin [50,51]. For example, 1-octen-3-ol and 1-butoxy-2-propanol are traditionally known as 
microbially emitted VOC [50]. However, recent work suggests that they are more likely to be emitted 
from PVCs at home, glues and other building structural material To date, a great deal of confusion 
exists regarding the true sources of common VOCs of indoor origin [50,51]. For example, 1-octen-3-ol 
and 1-butoxy-2-propanol are traditionally known as microbially emitted VOC [50]. However, recent 
work suggests that they are more likely to be emitted from PVCs at home, glues and other building 
structural material [36]. Furthermore, 2-ethyl-1-  x                               MVO        “     
                 ”          [52]. However, 2-ethyl-1-hexanol could also be produced as a 
by-product of di-2-ethylhexyl phthalate (DEHP) degradation [53]. 2-ethyl-1-hexanol from newly 
painted home indoor surfaces are significantly associated with asthma symptoms and airway 
inflammatory symptoms in a population-based survey of adults [52]. Another common plasticizer, 
2,2,4-trimethyl-1,3-pentanediol diisobutyrate (TMPD-DIB, also known as TXIB) possesses adjuvant 
properties, including allergic airway inflammation, heightened production of IL-12, and oxidative 
stress in allergen sensitized mice [32]. 2,4-trimethyl-1,3-pentanediol monoisobutyrate (TMPD-MIB, 
also known as Texanols
TM
) is globally distributed coalescing agents in latex (i.e. water-based) paints, 
91 
 
AIMS Environmental Science  Volume 2, Issue 1, 87-109. 
print-ink, and PVC flooring material [54]. Non-occupational exposure to TXIB and Texanols
TM
 in the 
general population is a concern because they are detected in considerable concentrations in ambient air 
in the city of Los Angeles [54], newly painted and installed housing units [55,56,57], and in food 
packed in polystyrene and polypropylene cups [58]. Furthermore, both TXIB and Texanols
TM
 
represent some of the most common VOCs within the temporary housing units constructed by the US 
Federal Emergency Management Administration for the families displaced by Hurricane Katrina in 
2005 [56].  
3.1.3. Secondhand smoke exposure(SHS) 
SHS is a well-known risk factor for asthma [59]. Second-hand smoke (SHS) is composed of >      
                             mutagens/carcinogens, developmental toxicants, and irritants [60].          
 x                                                                          growth [61] and cognitive 
functioning during childhood [62], as well as exacerbation of childhood asthma and with allergic 
response [63]. Furthermore, SHS is a primary delivery mode of other VOCs, including benzene, 
toluene and styrene in the US population [64]. 
3.1.4. Vitamin D 
Higher confinement to indoor life (and associated deprivation from sunlight) can lead to vitamin 
D insufficiency with concomitant increases in exposure to indoor pollutants. A vitamin D deficiency is 
associated with chronic lung disease [65], which likely relates to less control of the inflammation and 
oxidative stress induced by the indoor air. Vitamin D insufficiency (serum level of 25(OH)D < 30 
ng/mL) is common among children in the United States [66,67]. Among children aged 6–11 years, 
vitamin D deficiency was approximately 62% in non-Hispanic whites, approximately 86% in 
Hispanics, and approximately 96% in non-Hispanic blacks [66]. Prior work has shown that Vitamin D 
deficiency leads to impaired Th1 and Th17 lymphocyte function [68]. Furthermore, it has also been 
associated with reduced activity of FoxP3 functions in Treg cells [68].              O             
          implicated in asthma due to its correlation with  x                 resultant tissue damage, and 
airway inflammation [69]. In addition, cytokine production of cord blood T cells is correlated with 
season [67,70]. Thus, season could influence the exposure to home indoor toxicants by promoting the 
family members to reduce the home ventilation rate, nutritional intake of food items rich in vitamins 
(e.g., spinach, kale, collards, soy beans, and rainbow trout), sunlight (thereby, vitamin D) or maternal 
infection, as well as the asthma outcome [67,70]. 
3.2. Childhood immune markers and asthma risks 
3.2.1. A definition of immune system impairment 
Developmental alterations during early life in the immune system is thought to underlie 
subsequent allergic diseases [71]. A hallmark of such pre-clinical events consists of preferential 
enhanced development of the CD4
+
 type-2 helper T cells (Th2) [72]. Within this review, we narrow the 
scope of altered immune system development as skewed T-cell differentiation, including Th1, Th2, 
Th17 and regulatory T (Treg) cells, and innate immune cells.  
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3.2.2. Biomarkers of immune system impairments 
Several indoor environmental exposures to modern chemicals (from building material, consumer 
product uses, and lifestyle) within a damp home indoor environment (contributed by structural water 
damage, poor ventilation, and/or low temperature) have been shown to contribute to altered 
development of fetal innate and adaptive immune cells [34,73,74,75,76]. A critical event in this 
process is the unbalanced development of Th1 and Th2 cells [72]. The Th2 phenotype naturally 
dominates during fetal development, but environmental pollutants are suggested to maintain or 
enhance this imbalance after birth. Accordingly, unclear events preceding Th1/Th2 imbalance and 
identification of high risk newborns represent key barriers to our understanding of this process [71]. 
An improved understanding of prenatal exposure to indoor synthetic pollutants and the risks on 
prolonging the Th1/Th2 cell imbalance represents the main challenge to aid interventions, which limit 
risks during pregnancy. 
 
Figure 1. Proposed conceptual model. 
A c                                                         M       -                     
                         indoor exposure to VOCs, other susceptibilities                 
                                                                                                   
          activate innate immune cells (e.g., NK cells, macrophages, neutrophils). Such multiple-hits 
promulgate inflammation and resultant oxidative stress, further skewing maternal T cells toward Th2 
development [77], while suppressing T regulatory (Treg) cells and the associated Foxp3 gene 
expression [78]. Suppression of maternal Treg                                                       
                                    cells as markers of pre-clinical, immunotoxic consequences in 
newborns. Here, we posit that Th2 cells, which release interleukin (IL)-4, IL-5, and IL-13 promote 
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asthma. Increased IL-4 production heightens the IgE level, which arms mast cells and basophils for 
their detrimental allergen-induced release of bronchoconstrictor mediators [79]. IL-5 increases the 
presence of eosinophils [79] and IL-13 increases bronchoconstriction. Therefore, environmental 
factors that cause a Th1-Th2 imbalance in the prenatal or early postnatal period, in particular, T-cell 
polarization toward Th2 reactivity, may contribute to the risk of allergic disease. Genetic associations 
have also connected asthma, inflammation, and atopy [80], which further supports our proposed 
analysis of the associations of environmental exposures, immune biomarkers, and asthma severity. 
3.3. Exposome 
There are three biosystems (maternal, fetal, and placental), which need to be considered for the 
exposomic investigation of prenatal effects. Each of these biosystems has an influence on the health of 
offspring for their lifetime after maternal exposure to environmental stressors. The placenta is grouped 
as a separate entity, because it is not a permanent organ of either the mother or offspring, it is an 
intertwined mix of maternal and fetal cells, and its physiological presence is vital for fetal existence. 
The lifetime consequences of developmental exposures modulate both the immunity [81,82] and behavior 
of offspring [83,84]. The exposomal composite [21,85,86] begins at conception, but the constant and 
consistent interplays of environment and genetics affect health throughout the lifetime. Developmental 
exposomics includes the analyses of all exogenous environmental (biological, chemical, and 
psychological/physical) stressors on these three biosystems and the resultant effects on endogenous 
cellular and molecular activities, which affect health. These include the     ’                      
repair, or further damage in response to the varying environmental influences [87]. The effects of 
prenatal exogenous stressors and the endogenous responses to the environmental modulators, which 
depend on the fetomaternal genotypes, determine whether a disorder/disease will occur with greater 
prevalence within the lifetime of the offspring. The exposome paradigm suggests that pollutants must 
be eval                                                          “           ”                  
environmental influences, including diet and life-style behaviors, which includes psychological and 
physical stress, and that the environmental influences are dependen                ’  genetics [88]. 
Consideration of potentiated effects are especially important for exposomic analysis since two 
different stressors may induce no detectable effect on separate pathways, but these pathways converge 
leading to a detrimental response [84]. 
As the fetus develops, the metabolomics [89] and proteomics of the mother, placenta (the 
interconnecting fetomaternal barrier) and fetus regulate the constituents for fetal growth and 
differentiation. At conception and later in gestational development, environmental stressors, including 
air pollutants, have been reported to affect the prevalence of asthma in the offspring [90,91]. It seems 
somewhat incongruous that an air pollutant, which affects the maternal lung could affect fetal 
development. However, some pollutants may directly permeate to the placenta and fetus and other 
pollutants may induce endogenous maternal cellular and molecular changes that transmit the lung 
exposure to the placenta and fetus [92,93,94]. It is especially interesting to note that mast cells in the 
lung interstitium and alveolar epithelium and in close proximity to the vascular and nervous system 
networks are implicated in asthma, because mast cells also play an important role in placenta 
development. The airways of asthmatic individuals have increased presence of mast cells, and mast 
cells have been suggested to enhance the asthmatic pathology [95,96,97]. Mast cell release of 
histamine and proteases occurs with ozone exacerbation of asthma [98,99,100,101,102]. Mast cells are 
94 
 
AIMS Environmental Science  Volume 2, Issue 1, 87-109. 
often considered to play a role in allergic asthma with regard to antigen-specific allergen triggering via 
IgE. However, mast cells and other innate immune cells can enhance asthma with pattern recognition 
receptor (PRR)-induced release of prostaglandins and other inflammatory factors due to exposure to 
pathogen-associated molecular patterns (PAMPs). The involvement of innate immune cells in asthma 
may be one reason why inhaled corticosteroids (ICS) sometimes have little effect, in that ICS have 
minimal influence on the number of mast cells in asthmatic lungs [103] and on 
bronchoconstriction[104].  
Air pollutants can modulate placenta structure and function [105,106,107,108,109], including 
immune activities associated with the placenta [110]; thus, it is not surprising [110]; that they either 
directly affect the placenta and fetus or rely on transited maternal cells and molecules. Hematopoietic 
mast cells have been suggested to play a role in implantation and placenta development [111,112], 
which affects offspring birth weight. Mast cell activity and other immune activities in the placenta 
affect placenta size, which can affect birth weight. Mast cells [113] and air pollutants [113] and air 
pollutants [114,115,116] also have been linked to preeclampsia. The placenta controls bidirectional 
trafficking of cells and molecules, and thus plays an intermediary role in the fetomaternal relationship. 
Asthma is a multifaceted inflammatory disease of the airways that usually includes increased 
mucus production, bronchorestriction, and airway remodeling. Whether asthma is classified as allergic 
or non-allergic immune cells producing similar cytokines and chemokines are implicated. Allergic 
asthma involves mainly adaptive lymphocytes including CD4
+
 Th2 cells producing IL-4, IL-5, and 
IL-13. IL-4 promotes B lymphocyte switching to the IgE antibody isotype, which arms mast cells and 
basophils with antigen-specific signaling. IL-5 promotes the growth and differentiation of eosinophils, 
and IL-13 promotes contraction of airway epithelial cells and smooth muscle cells. Non-allergic 
asthma involves innate lymphocytes of different classes referred to as innate lymphoid cells (ILC)1, 
ILC2 and ILC3 [117], which respond to PAMPs with their PPRs and produce IL-4, IL-5, IL-13 and 
IL-17.                                                 ’           ’                                
phenotype via epigenetic modulations as the naïve T cells are induced to proliferate. As the offspring 
gets exposed to the non-aseptic environment at birth further epigenetic modulation generally leads to a 
more balanced ratio of Th1 and Th2 cells; however, prenatal and postnatal environmental influences, 
including ozone, cigarette smoke, diesel exhaust and other airborne pollutants seem to enhance the 
continuation of the Th2 dominance [118]. With regard to allergic asthma the enhanced maintenance of 
the Th2 imbalance may be due to the phenotype of the antigen presenting cells (APCs). Alternatively, 
activated macrophages or M2 macrophages or dendritic cells preferentially activate Th2 cells. 
Ox                                                                             G            ’       
anti-oxidant) and APCs with less GSH preferentially activate Th2 cells [118,119,120]. Interestingly, 
GSH loss has been implicated in the induction of asthma due to numerous airborne metabolites 
exposures that can generate oxidative stress [121]. Prenatal exposure to acetaminophen also influences 
the risk of wheezing incidence at age 5 due to GSH variance [122]. Oxidative processes from prenatal 
exposures to cigarette smoke [123,124], polycyclic aromatic hydrocarbons [125], PCBs [126], 
phthalates [127], and bisphenol A [128] are likely due to aryl hydrocarbon receptor (AHR) 
activation[129], which promotes inflammation and asthma; these pollutants are known to activate 
AHR [129,130]. 
Allergic asthma is often of low or moderate severity with a relatively low level of airway 
remodeling although it is as chronic as the more severe form. Severe asthma with more recurrent 
exacerbations usually involves a greater extent of inflammation with a greater presence of neutrophils 
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and eosinophils. Severe asthm                    I  γ     I -17 from Th1 and Th17 cells or ILC2 
and ILC3 cells. The ILC2 and ILC3 subsets are lineage negative cells; whereas, the ILC1 subset 
includes NK cells. ILC2 and ILC3 cells are IL-7R positive; IL-7 is produced by hematopoetic stromal 
cells, and it supports early lymphoid progenitor differentiation of the stem cells. The ILC2 population 
is very similar to the Th2 population with regard to its cytokine profile; it develops in the presence of 
IL-25 and IL-33, and like Th2 cells, it expresses the GATA-3 transcription factor. IL-33 is a nuclear 
protein released by airway epithelial cells damaged by airborne pollutants; it is referred to as a 
damage-associated molecular pattern molecule (DAMP) or as an alarmin and is activated by cleavage 
with mast cell protease [131]. Th2 and ILC2 cells, mast cells, basophils and eosinophils are stimulated 
by IL-33. Another stimulator of ILC2 cells is thymic stromal lymphopoietin (TSLP) [132], which like 
IL-33 is released from airway epithelial cells and smooth muscle cells [133]. Damaged airway cells 
also release ATP [133]. Damaged airway cells also release ATP, which recruits and activates mast 
cells[134,135]; via ATP-induced activation of the inflammasome, cleaved active form of IL- β    
produced [136], which also recruits neutrophils and Th17 cells, and inflammation and airway 
remodeling is enhanced [137]. 
3.3.1. Utility 
Attraction and promise of Exposome-Wide Association Studies (EWAS) lie in distinguishing 
biomarkers of exposure from biomarkers of disease phenotype [88,138]. Recent blood-based 
exposomic analyses have shown their potential to capture multiple environmental factors, including 
the nutrients [139], viral infection [140], the microbiome [141], stress [142], and environmental 
toxins[143]. For example, preterm delivery as well as fetal growth restriction has been shown to be 
associated with urinary levels of acetate, tyrosine, formate, trimethylamine, lysine and glycoprotein [144]. 
Rappapport (2012) proposes a two-phase strategy for exposomic investigation of the disease 
outcomes. Within the first phase, molecules are scanned through an agnostic search tool for their 
association with the disease outcome status [138]. The second stage investigation is often directed to 
investigate the role of the metabolites (identified in the first phase) as causal contributors or 
intermediate players in pathophysiology of the clinical phenotypes [145]. The first phase of the 
analyses is often conducted through liquid-chromatography tandem mass spectrometry (LC-MS/MS) 
or nuclear magnetic resonance (NMR) spectroscopy [146]. Each has advantages and shortcomings. 
LC-MS offers the advantage of greater sensitivity of molecules in biofluids (e.g., ~4000 molecules 
within plasma sample) and better molecule discrimination [146]. On the other hand, NMR detect[146]. 
On the other hand, NMR detects relatively smaller set of particles (< 200). But, the NMR does not 
destruct the sample, thus permitting repeated analysis [146]. Furthermore, application of LC-MS/MS 
is also limited by the fact that existing libraries are too small to identify most of the detected 
molecules[147]. To date, interpretability of many metabolomics analyses remain extremely limited 
due to fragmentations or adduct formations [148]. To date, statistical methodology regarding pattern 
recognition remains the major challenge associated with metabolomics analysis. The challenge lies not 
only in the association of biomarkers with the disease outcome of interest, but also in clarifying the 
relevance of a given biomarker in a pathophysiological process [145]. Given the preliminary nature of 
small molecular biomarkers for phenotypic analyses, independent validations in order to account for 
the high-dimensionality of the analyses and the associated false discovery rates represent critical steps 
in identification of true disease outcome markers [138].  
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3.3.2. Urinary metabolomics 
Metabolomics captures a comprehensive catalogue of small molecules (molecular weight < 
1500 Daltons) within any organic systems or physiological state [149]. Urine metabolomic profiling 
holds promise as a non-invasive and unbiased wind          “              ”                        
status for newborns and children [145]. For example, within a murine model of asthma, administration 
of dexamethasone induced a marked, yet, reversible metabolism of carbohydrate, lipid, and sterol in 
bronchoalveolar lavage fluid from asthmatic lungs [149]. 
Within a clinical setting, the urinary metabolic profile of preterm and term infants were distinctly 
unique according to the gestational age at delivery [150]. In particular, preterm status was associated 
with altered patterns of: 1) tyrosine metabolism; 2) the biosynthesis process of tyrosine, tryptophan, 
and phenylalanine; 3) urea cycle; 4) arginine metabolism; and 5) proline metabolism [150]. Furthermore, 
co-morbid condition of extremely low weight as well as preterm delivery status was associated with 
altered arginine-proline metabolism, purine-pyrimidine metabolism, and urea cycle during 
adulthood[150]. In another pilot investigation of children with nephron-uropathies (renal dysplasia, 
vesico-ureteral reflux, urinary tract infection, or acute kidney injury) versus healthy children, the 
disease status was associated with an alteration in the urea cycle as well as purine and pyridine 
synthesis [150]. Metabolic profiling of asthmatic versus healthy control children using liquid 
chromatography—mass spectrometry (LC-MS) demonstrated lower levels of urocanic acid and 
methyl-imidazoleacetic acid in the asthmatic children compared to the controls [148]. Both urocanic 
acid and methyl-imidazoleacetic acid play a role in inflammatory responses. Overall, the number of 
studies for the identification of the biomarker using this technology remains extremely limited due to 
the limitations in analytical chemical techniques as well as the computational and bioinformatic 
tools[145]. 
3.3.3. Predictive value of metabolomic profile for asthma 
Undirected metabolomics refers to the comprehensive measurement of all small molecules within 
a given sample. Such data is subsequently cleaned into a small set of signals and qualitatively 
recognized through in silico searches of existing libraries or ionization experiments [151]. While this 
approach has [151]. While this approach has potential for the identification of novel biomarkers, a 
number of potential issues with such biomarkers have also been identified [145]. One of the critical 
issues relate to the erroneous identification of noise rather than a signal [145]. Even when a meaningful 
signal is detected, the biological relevance of the signal to underlying etiological process remains a 
challenge [145]. For example, Nuclear Magnetic Resonance (NMR) based metabolomic analysis 
applied to exhaled breath condensate demonstrated greater sensitivity to discriminate asthmatic 
children (86% sensitivity) compared to that based on exhaled nitric oxide and Forced expiratory 
volume (FEV1) with 81% sensitivity [152]. However, the exact molecular identity could not be 
determined based on the NMR technique [152]. Thus, the issues of biological plausibility, 
reproducibility of the identified set (through second stage analysis) as well as confounding need to be 
addressed [145]. To date, most investigations have been able to identify only the biomarkers of clinical 
outcome status (e.g. cardiac ischemia) [145]. Thus, the development of predictive metabolomics 
biomarkers of disease outcome is needed as diagnostic tool. 
In contrast, directed metabolomics refers to a more focused search of selected set of known and 
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expected metabolites using tandem mass spectrometry (MS/MS), or selected ion recording (SIR) with 
GC-MS [151]. Some investigators have used the targeted search as a validation tool for preliminarily 
identified set of metabolites [145]. 
3.3.4. Computational systems biology and its application to asthma 
Computational modelling includes an array of quantitative techniques that can be used to assess 
health risk. The computational modelling offers the advantage of interpreting preliminarily identified 
signal in the second stage of exposomic investigation. Furthermore, the computational models could 
account for the underlying uncertainties inherent within complex biological systems and their response 
to environmental exposure. The type of model depends on the nature of the system to be 
modelled[153]. Historically, the physiologically based pharmacokinetic [153]. Historically, the 
physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model has been routinely 
employed in toxicological studies [154].                               ’    x                       
to evaluate normal tissue limitations to chemical exposure (Figure 2). These models need information 
on the pollutants, including its absorption, distribution, metabolism, and elimination (ADME). In 
addition, information about the organ size, ventilation rates, the age, and the gender of the organism, 
 
Figure 2. Generic structure of the PBPK modelling framework.  
together with the hypothesized mechanistic information are required. PBPK modelling in early life has 
been used to determine toxicant exposure in children [155,156], however the focus has centered on drug 
metabolism and there is a paucity of models, which focus on environmental exposure and prenatal risk 
of developing asthma. In terms of prenatal exposures to toxicants, PBPK models have been used to 
quantify and characterize the physiological effects of drug exposure during pregnancy [157]. A 
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noteworthy development in PBPK modelling is the development human PBPK model toolkit by 
recoding published PBPK models [158]. This toolkit is expected to provide a straightforward reference 
point to a wide variety of models of this nature. The last decade and a half has also witnessed the 
growth of the systems biology paradigm as a framework for conducting toxicological 
investigations[159]. At the core of this new approach is computational systems biology [160]. The aim 
of computational systems biology is to use mathematics to describe complex biological phenomena in 
a quantitative manner using computer simulations (Figure 3). There is also an emphasis on using the 
models to study biological systems in a holistic manner as opposed the more reductionist approach that 
is often adopted in the wet-laboratory [161]. Several different mathematical approaches can be used 
when designing a computational systems model. These different mathematical approaches were 
recently reviewed in detail [162]. By far the most ubiquitously adopted mathematical approach is to 
use ordinary differential equations (ODEs). This method is similar in nature to PBPK models, in that, 
model reactions are informed by kinetic data and steady-state information about the biological system  
 
Figure 3. The steps involved in constructing a computational systems biology model. 
under investigation. A disadvantage of these models is that they cannot include variability or spatial 
dynamics as part of the behavior of the biological system. Another disadvantage is that kinetic 
information is often difficult to obtain, despite a number of archives for online kinetic data [163]. 
Parameterizing such models is also challenging especially as the size of model increases [164]. A 
pertinent example of how an ODE model can dovetail with wet-laboratory experimentation is recent 
work by Carbo et al. (2014) which was used to investigate the role of interleukin-21 (IL-21) in the 
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gastric mucosa during H. pylori infection [165]. Computational systems modelling has been used to 
model CD4
+
 T cell differentiation with in vivo mechanistic studies. The model predicted activated 
expression of T-        RORγ                                                             
potential role of IL-21 in the modulation of IL-10. This combined approach indicated that IL-21 
regulates Th1 and Th17 effector responses during chronic H. pylori infection in a STAT1- and 
STAT3-dependent manner, and are thus regulators of the H. pylori infection. Of significance for this 
review is that it suggests H. pylori colonization protects against childhood asthma [166,167]. 
Therefore, this study outlines a way in which the immune system can be studied mechanistically by 
using a combined in vivo in silico approach. Stochasticity in systems models can be dealt with by using 
stochastic differential equations which represent biological reactions as discrete random molecular 
collisions. Such models often represent scenarios involving low molecule numbers such as protein 
molecules from an expression of a single gene [168]. The major disadvantage of such models is that 
they are computationally slow. Variability can also be represented by using Bayesian networks. This 
type of modelling is useful for making toxicant risk estimates [169]. Petri nets can also be used to 
construct a systems model. These are a special type of model which comprises of two nodes, called 
places and transitions. Places and transitions are connected using arrows. Each place contains a 
number of tokens which is the same as a discrete number of biochemical molecules. A Petri net 
functions by input-                      ‘           ’                         ‘      ’                
represents a reaction taking place within a biological system [170]. There are a number of different 
standards for exchanging computational models, with the Systems Biology Markup Language (SBML) 
leading exchange format for the exchange of biological models at present [171]. This format is 
designed to be used for exchange independent of the modelling tool used to construct the model. 
Another more recent development from a purely toxicological perspective is the development of 
adverse outcomes (AOPs) [172]. AOPs are in essence are a way of having a mathematical 
representation which is informed by our current understanding of a biological pathway and how a 
change to that pathway could have an adverse outcome at the level of a whole organism or even 
population level [172]. Of note for this review is that this novel modelling methodology has been 
applied to studies which have investigated respiratory allergies [173]. The stages in building an AOP 
include determining the information required to represent the pathway of interest. A summary is then 
included in the form of a flow chart that depicts the AOP from molecular initiation even to its effect on 
the whole organism. The weight of the interaction is determined together with a confidence 
determination [174]. In light of developments such as those outlined in this section computational 
modelling will be applied further to both pre and post natal exposure to chemicals investigations. 
3.3.5. Is external validation necessary within exposome? 
In contrast to biomarker driven definition of exposome [138], the US National Research Council 
         x          “     x            x                                                              
receptor inward into the organism and outward to the general environment, including the 
         ”[175]. 
Within the context of asthma investigation, the more holistic definition proposed by the National 
Research Council is needed for the following reasons.  
First, since most metabolomics studies have been of pilot-scale, validation of the biomarkers both 
within- as well as between-persons remains exceedingly rare. Furthermore, underlying 
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representativeness of the diseased versus healthy controls remains relatively poorly understood. For 
example, age-dependent appearance of the asthma phenotype requires validation of initial 
identification. 
Second, temporal variability in external and internal exposures remains unknown [176]. At best, 
they are measured with substantial error [176]. Lack of valid and accurate exposure assessment data 
represents an important barrier to the understanding of true human exposure [11,13]. The nature of 
specific pollutants and the concentrations of presumed personal exposures remain unknown. In spite of 
these, predominant methodological approaches of asthma investigations rely on cross-sectional 
design[35,177,178,179]. Cross-sectional design is inherently limited in its ability to reject the 
possibility that risk factors (e.g. water-based cleaning) were adopted following the health outcome 
occurrence. In addition, most investigations rely on surrogate  x                                  
                                                                                       renovation, or 
flooding) rather than direct measurement [13,24,25]. 
4. Conclusion 
An improved understanding of the mechanistic processes underlying immune system 
impairments, early detection, and source removal are critical for prevention of asthma as a globally 
burdensome group of illnesses. This review considered damp home environments, emission and/or 
retention of VOCs from cleaning chemicals, latex paints, adhesives, rotting plasticizers, other aging 
furniture and structural material in homes as a context for exposure during early-life. We propose 
consideration of context of exposure within the application of targeted exposomic investigations. Such 
context holds promise for biomarker identification for asthma diagnosis, severity prediction, as well as 
clarification of pathophysiological processes. We propose an exposome as an integrated investigative 
approach in which comprehensive environmental media sampling, metabolomic profiling of 
biological samples, and second-stage investigation of biomarker relevance are considered together in 
an iterative process. 
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